摘要
Objective To study the safety and efficacy of colistin monotherapy versus combination therapy against carbapenem-resistant gram-negative bacteria infection.Methods CNKI,Wanfang database,PubMed,Embase and Cochrane library were systematically searched.Randomized controlled trials about colistin monotherapy versus combination therapy against carbapenem-resistant gram-negative bacteria infection were enrolled.The Cochrane Reviewers Handbook 5.2 was employed to evaluate the quality of the enrolled studies.
作者
MENG Haiyang
孟海阳(Dept Pharm,1st Affil Hosp,Zhengzhou Univ,Zhengzhou 450052)